Biotech Values

[turtlepower]

ACHN - Thanks for your excellent CC notes. While I agree that it appeared that the results were being severely pumped (dietrich joking about Mount Sinai being used as a potential trial site may not have helped), it appeared that ACHN mainly had dietrich over to provide a different perspective. An impressive number of analysts from pretty much all the major firms called in and the first question was addressed to Dietrich so his presence was useful. I wonder though whether they would be able to get good terms when a potential partner knows that a next gen PI is waiting in the wings. It seems to me a potential partner would also want a part of a next gen compound in addition to the current one.